These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis. Roberge FG; Lorberboum-Galski H; Le Hoang P; de Smet M; Chan CC; Fitzgerald D; Pastan I J Immunol; 1989 Dec; 143(11):3498-502. PubMed ID: 2511243 [TBL] [Abstract][Full Text] [Related]
3. Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. Case JP; Lorberboum-Galski H; Lafyatis R; FitzGerald D; Wilder RL; Pastan I Proc Natl Acad Sci U S A; 1989 Jan; 86(1):287-91. PubMed ID: 2492102 [TBL] [Abstract][Full Text] [Related]
4. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes. Lorberboum-Galski H; Garsia RJ; Gately M; Brown PS; Clark RE; Waldmann TA; Chaudhary VK; FitzGerald DJ; Pastan I J Biol Chem; 1990 Sep; 265(27):16311-7. PubMed ID: 1975810 [TBL] [Abstract][Full Text] [Related]
5. Increased cytotoxicity of interleukin 2-pseudomonas exotoxin (IL2-PE) chimeric proteins containing a targeting signal for lysosomal membranes. Fishman A; Bar-Kana Y; Steinberger I; Lorberboum-Galski H Biochemistry; 1994 May; 33(20):6235-43. PubMed ID: 8193138 [TBL] [Abstract][Full Text] [Related]
8. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response. Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661 [TBL] [Abstract][Full Text] [Related]
10. Cardiac allograft survival in mice treated with IL-2-PE40. Lorberboum-Galski H; Barrett LV; Kirkman RL; Ogata M; Willingham MC; FitzGerald DJ; Pastan I Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1008-12. PubMed ID: 2644640 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin. Ogata M; Chaudhary VK; FitzGerald DJ; Pastan I Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4215-9. PubMed ID: 2657746 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin. Puri RK; FitzGerald D; Leland P; Kozak RW; Pastan I Cell Immunol; 1992 Sep; 143(2):324-34. PubMed ID: 1511480 [TBL] [Abstract][Full Text] [Related]
13. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism. Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876 [TBL] [Abstract][Full Text] [Related]
14. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines. Vandenbark AA; Nilaver G; Konat G; Teal P; Offner H J Neurosci Res; 1986; 16(4):643-56. PubMed ID: 2432277 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of a synapsin peptide genetically fused to the B subunit of Escherichia coli heat-labile enterotoxin in rat autoimmune encephalomyelitis. Scerbo MJ; Rupil LL; Bibolini MJ; Roth GA; Monferran CG J Neurosci Res; 2009 Aug; 87(10):2273-81. PubMed ID: 19267420 [TBL] [Abstract][Full Text] [Related]
16. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats. Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081 [TBL] [Abstract][Full Text] [Related]
17. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. Batra JK; FitzGerald D; Gately M; Chaudhary VK; Pastan I J Biol Chem; 1990 Sep; 265(25):15198-202. PubMed ID: 2118522 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels. Siegall CB; FitzGerald DJ; Pastan I J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904 [TBL] [Abstract][Full Text] [Related]
19. Treatment of corneal allograft rejection with the cytotoxin IL-2-PE40. Herbort CP; de Smet MD; Roberge FG; Nussenblatt RB; FitzGerald D; Lorberboum-Galski H; Pastan I Transplantation; 1991 Sep; 52(3):470-4. PubMed ID: 1897019 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. Kunwar S; Pai LH; Pastan I J Neurosurg; 1993 Oct; 79(4):569-76. PubMed ID: 7692018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]